| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||
Net Income (Loss) Attributable to Parent | ||||||||||
11,600 | 3,300 | -26,800 | -28,879 | -73,520 | -51,500 | -44,974 | -51,867 | -45,831 | -61,159 | -72,344 |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | ||||||||||
27,900 | 15,600 | 13,900 | 13,833 | 15,838 | 12,223 | 11,806 | 11,030 | 8,503 | 5,077 | 5,222 |
Non-cash interest | ||||||||||
35,600 | 29,300 | 18,000 | 10,068 | 7,678 | 10,253 | 9,731 | 10,212 | 9,736 | 1,779 | 677 |
Amortization of debt discount | ||||||||||
- | - | - | - | - | - | - | - | - | 13,265 | 5,585 |
Stock-based compensation | ||||||||||
28,700 | 37,500 | 31,900 | 23,617 | 19,178 | 22,519 | 12,683 | 9,920 | 7,734 | 5,064 | 4,202 |
Gain (Loss) on Extinguishment of Debt | ||||||||||
-8,700 | 0 | -600 | -2,551 | 0 | -23,203 | -325 | 0 | - | - | - |
Provision for credit losses | ||||||||||
4,500 | 3,400 | 1,900 | 2,070 | 1,184 | 3,254 | 4,741 | 3,409 | 3,165 | 3,317 | 5,020 |
Impairments and other | ||||||||||
- | - | - | 6,234 | 9,086 | 0 | 2,511 | 0 | 0 | - | - |
Other | ||||||||||
1,100 | -400 | 100 | - | - | - | - | - | - | - | - |
Restructuring and impairment of assets | ||||||||||
- | - | - | - | - | - | - | - | - | 4,432 | - |
Deferred tax provision | ||||||||||
- | - | - | - | - | - | - | - | -11,289 | - | - |
Changes in operating assets and liabilities: | ||||||||||
Accounts receivable | ||||||||||
10,900 | 22,900 | 26,300 | -12,551 | 9,793 | 10,069 | 4,514 | 13,513 | 3,617 | 5,196 | 6,972 |
Inventories | ||||||||||
30,200 | 38,800 | -1,700 | 24,103 | 722 | 3,635 | -5,403 | 3,029 | -1,879 | 1,343 | -5,843 |
Prepaid expenses and other assets | ||||||||||
21,900 | 11,600 | 3,300 | 2,621 | 1,460 | -662 | 320 | 898 | -853 | -381 | -646 |
Accounts payable, accrued expenses and other current liabilities | ||||||||||
36,200 | 21,200 | 27,300 | 639 | 17,986 | 525 | 10,425 | 2,999 | 4,697 | -1,139 | 1,487 |
Deferred revenue | ||||||||||
-2,000 | 3,800 | -1,100 | 849 | 809 | 654 | -4,545 | 2,863 | -1,665 | 277 | 1,593 |
Other liabilities | ||||||||||
5,100 | 3,100 | 1,200 | 800 | 1,184 | 831 | 76 | -185 | 383 | -380 | -282 |
Net cash (used in) provided by operating activities | ||||||||||
98,400 | 35,900 | 41,300 | 15,911 | -12,552 | 8,920 | 3,348 | -29,059 | -25,452 | -35,625 | -49,323 |
Cash flows from investing activities | ||||||||||
Capital expenditures | ||||||||||
163,700 | 157,400 | 73,800 | 22,115 | 10,608 | 11,486 | 7,307 | 10,991 | 11,114 | 6,549 | 3,140 |
Acquisition of intangible assets | ||||||||||
7,200 | 5,000 | 3,400 | - | - | - | - | - | - | - | - |
Purchases of investments | ||||||||||
150,600 | 191,400 | 298,000 | 177,654 | 0 | 0 | - | - | - | - | - |
Receipts from the maturity or sale of investments | ||||||||||
247,900 | 169,300 | 164,400 | 16,045 | 0 | 0 | - | - | - | - | - |
Proceeds from divestiture of business, net | ||||||||||
- | - | - | 5,714 | 0 | 0 | - | - | - | - | - |
Acquisition of business | ||||||||||
- | - | - | - | 4,715 | 0 | 0 | - | - | - | - |
Acquisition of Neighborhood Diabetes | ||||||||||
- | - | - | - | - | - | - | - | 37,855 | - | - |
Net cash provided by investing activities | ||||||||||
-73,600 | -184,500 | -210,800 | -178,010 | -15,323 | -11,486 | -7,307 | -10,991 | -48,969 | -6,549 | -3,140 |
Cash flows from financing activities | ||||||||||
Proceeds from exercise of stock options | ||||||||||
- | - | - | - | - | 11,586 | 102,652 | 4,927 | 5,460 | 48,683 | 94,417 |
Principal payments of capital lease obligations | ||||||||||
0 | 0 | 300 | 5,518 | 5,576 | 3,858 | 994 | 0 | 0 | - | - |
Proceeds from issuance of convertible debt, net of issuance costs | ||||||||||
780,200 | 0 | 391,600 | 333,725 | 0 | 194,490 | 0 | 0 | 138,783 | - | 56,879 |
Purchase of capped call options | ||||||||||
85,400 | 0 | 0 | - | - | - | - | - | - | - | - |
Repayment of convertible debt | ||||||||||
663,600 | 6,700 | 98,500 | 153,628 | 0 | 189,521 | 2,000 | 0 | 88,195 | 32,500 | 27,500 |
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan | ||||||||||
50,900 | 15,800 | 15,800 | 4,854 | 7,851 | - | - | - | - | - | - |
Payment of transaction fees related to the credit facility amendment | ||||||||||
- | - | - | - | - | - | - | - | - | -468 | - |
Proceeds from exercise of warrants | ||||||||||
- | - | - | - | - | - | - | - | - | 11,737 | - |
Payment of withholding taxes in connection with vesting of restricted stock units | ||||||||||
8,600 | 17,800 | 4,100 | 2,866 | 2,646 | 8,665 | 3,265 | 1,539 | 946 | - | - |
Net cash (used in) provided by financing activities | ||||||||||
73,500 | -8,700 | 304,500 | 176,567 | -371 | 4,032 | 96,393 | 3,388 | 55,102 | 27,452 | 123,796 |
Effect of exchange rate changes on cash | ||||||||||
1,500 | -1,400 | 400 | 34 | -275 | 0 | 0 | - | - | - | - |
Net (decrease) increase in cash, cash equivalents and restricted cash | ||||||||||
99,800 | -158,700 | 135,400 | 14,502 | -28,521 | 1,466 | 92,434 | -36,662 | -19,319 | -14,722 | 71,333 |
Supplemental cash flow information: | ||||||||||
Supplemental cash flow information | ||||||||||
Cash paid for interest, net of amount capitalized | ||||||||||
0 | 0 | 2,500 | 3,687 | 4,025 | 4,657 | 5,704 | 6,197 | 5,173 | 8,087 | 6,823 |
Cash paid for taxes | ||||||||||
2,500 | 800 | 500 | 932 | 109 | 124 | 321 | 11 | 263 | 11 | - |
Allocation to equity for conversion feature for issuance of convertible debt | ||||||||||
- | - | - | - | - | - | - | 0 | 0 | - | - |
Allocation to equity for conversion for the 2% Notes | ||||||||||
- | - | - | - | - | - | 0 | 0 | - | - | - |
Allocation of fair value of warrants from net proceeds from issuance of Facility Agreement | ||||||||||
- | - | - | - | - | - | - | - | - | - | 6,065 |
Common stock issued in exchange for 3.75% convertible notes | ||||||||||
- | - | - | - | - | - | - | - | 24,432 | - | - |
Purchases of property and equipment under capital lease | ||||||||||
- | - | - | - | 5,721 | 1,474 | 9,021 | 0 | 0 | - | - |
Purchases of property and equipment included in accounts payable and accrued expenses | ||||||||||
13,300 | 11,400 | 3,800 | - | - | - | - | - | - | - | - |
1.375% Convertible Senior Notes | ||||||||||
Allocation to equity for conversion feature for issuance of convertible debt | ||||||||||
- | - | - | 0 | - | - | - | - | - | - | - |
1.25% Convertible Senior Notes | ||||||||||
Allocation to equity for conversion feature for issuance of convertible debt | ||||||||||
- | - | - | 66,689 | - | - | - | - | - | - | - |
2% Convertible Senior Notes | ||||||||||
Allocation to equity for conversion feature for the repurchase of 2% convertible notes | ||||||||||
- | - | - | -32,865 | - | - | - | - | - | - | - |